Who owns Cytosorbents?
- Ticker: CTSO
- CUSIP Number: 23283x206
Tip: Access positions for across all investors
Analyze quarterly positions in Cytosorbents with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cytosorbents stock
Who bought or sold Cytosorbents this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Avenir Corporation | 5.2M | $3.0M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 1.9M | $1.1M | 100% | Mar 2026 |
|
| Neuberger Berman Group | 1.7M | $951k | 4% | Mar 2026 |
|
| CM Management | 1.5M | $836k | 0% | Mar 2026 |
|
| Skylands Capital | 1.2M | $453k | -29% | Jun 2026 |
|
| BlackRock | 783k | $443k | 2% | Mar 2026 |
|
| Geode Capital Management | 707k | $401k | 17% | Mar 2026 |
|
| Sargent Investment Group | 550k | $311k | -10% | Mar 2026 |
|
| Pathstone Holdings | 500k | $283k | 0% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 314k | $178k | 100% | Mar 2026 |
|
| CIBC Bancorp USA | 173k | $98k | 100% | Mar 2026 |
|
| State Street Corporation | 159k | $90k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 130k | $74k | 0% | Mar 2026 |
|
| UBS Group | 115k | $65k | 0% | Mar 2026 |
|
| Raymond James Financial | 108k | $61k | -1% | Mar 2026 |
|
| NWF Advisory Services | 104k | $39k | 0% | Jun 2026 |
|
| Renaissance Technologies | 101k | $57k | 1% | Mar 2026 |
|
| Morgan Stanley | 100k | $57k | -14% | Mar 2026 |
|
| Northern Trust | 93k | $52k | 0% | Mar 2026 |
|
| Key Client Fiduciary Advisors | 79k | $29k | 0% | Jun 2026 |
|
| Warren Averett Asset Management | 56k | $32k | 0% | Mar 2026 |
|
| Stifel Financial | 48k | $27k | 0% | Mar 2026 |
|
| Goldman Sachs Group | 44k | $25k | 22% | Mar 2026 |
|
| Bank of America Corporation | 39k | $22k | 100% | Mar 2026 |
|
| XTX Topco | 36k | $20k | 20% | Mar 2026 |
|
| Susquehanna International | 30k | $17k | -64% | Mar 2026 |
|
| Kestra Advisory Services | 28k | $11k | 0% | Jun 2026 |
|
| EP Wealth Advisors | 28k | $16k | 0% | Mar 2026 |
|
| Comprehensive Portfolio Management | 27k | $16k | 100% | Mar 2026 |
|
| LPL Financial | 23k | $13k | 1% | Mar 2026 |
|
| Creative Planning | 21k | $12k | 0% | Mar 2026 |
|
| Granite Springs Asset Management | 16k | $6.1k | 0% | Jun 2026 |
|
| Merit Financial Group | 15k | $5.7k | 0% | Jun 2026 |
|
| First National Bank Of Omaha | 15k | $8.5k | 0% | Mar 2026 |
|
| Hrt Financial | 14k | $7.0k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 14k | $7.8k | 100% | Mar 2026 |
|
| Texas Capital Bank Wealth Management Services | 11k | $6.2k | 0% | Mar 2026 |
|
| Citadel Advisors | 11k | $6.1k | -93% | Mar 2026 |
|
| Marathon Capital Management | 10k | $3.7k | 0% | Jun 2026 |
|
| Fifth Third Bancorp | 3.1k | $1.7k | 100% | Mar 2026 |
|
| Rockefeller Capital Management | 1.9k | $1.1k | -27% | Mar 2026 |
|
| Your Advocates | 250.00 | $143.000000 | 0% | Mar 2026 |
|
| Wells Fargo & Company | 250.00 | $142.000000 | -66% | Mar 2026 |
|
| MAI Wealth Advisors | 233.00 | $131.994500 | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 93.00 | $55.000200 | 0% | Mar 2026 |
|
| Pnc Financial Services | 31.00 | $17.998600 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 17.00 | $9.999400 | -15% | Mar 2026 |
|
| Farther Finance Advisors | 6.00 | $1.999800 | 0% | Jun 2026 |
|
| SBI Securities | 1.00 | $1.000000 | 100% | Mar 2026 |
|
Who sold out of Cytosorbents?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| GSA Capital Partners | Dec 2025 | 148k | $95k |
| Atomi Financial Group | Dec 2025 | 27k | $18k |
| Virtu Financial | Dec 2025 | 11k | $7.0k |
| Millennium Management | Dec 2025 | 10k | $6.5k |
| Tower Research Capital | Dec 2025 | 2.2k | $1.4k |
| FMR | Dec 2025 | 384.00 | $244.992000 |
| Medallion Wealth Advisors | Dec 2025 | 45.00 | $28.998000 |